$CABA SEC Filings

Filed On	Filing
14 Sep 2026	8-K: Other Events In connection with Cabaletta Bio’s (the “Corporation”) June 2025 underwritten public offering, the Corporation issued 53,090,190 common stock warrants (the “Common Stock Warrants”) that had an exercise price of $2.50 per whole share of i...
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
13 Aug 2026	10-Q
13 Aug 2026	8-K: Results of Operations and Financial Condition
12 Aug 2026	SCHEDULE 13G/A
12 Aug 2026	SCHEDULE 13G
31 Jul 2026	SCHEDULE 13G
27 Jul 2026	SCHEDULE 13G
23 Jul 2026	SCHEDULE 13G/A
11 Jun 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
10 Jun 2026	Form 4: Tomasello Shawn, Director Granted 22,000 Stock Option (Right to Buy)
10 Jun 2026	Form 4: Simon Mark, Director Granted 22,000 Stock Option (Right to Buy)
10 Jun 2026	Form 4: Henriques Richard C Jr, Director Granted 22,000 Stock Option (Right to Buy)
10 Jun 2026	Form 4: Bollard Catherine, Director Granted 22,000 Stock Option (Right to Buy)
10 Jun 2026	Form 4: Brun Scott C., Director Granted 22,000 Stock Option (Right to Buy)
05 Jun 2026	SCHEDULE 13G/A
04 Jun 2026	SCHEDULE 13G/A
03 Jun 2026	8-K: Regulation FD Disclosure; Other Events

Comments